BSEResult13 Aug 2026 · 13 Aug 2026, 02:09 pm
Financial Results pursuant to Regulation 33 of the SEBI (LODR) Reg, 2015
Desh Rakshak Aushdhalaya Ltd · 531521
✦ AI SummaryResults
Desh Rakshak Aushdhalaya Ltd has submitted its unaudited financial results for the quarter and year to date ended 30th June, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's revenue from operations for the quarter ended 30th June, 2026, was Rs. 82.83 lakhs, with a total revenue of Rs. 346.38 lakhs. The company's profit before exceptional and extraordinary items and tax for the quarter ended 30th June, 2026, was Rs. 8.03 lakhs.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Desh Rakshak Aushdhalaya Ltd - 531521 - Submission Of Quarterly And Year To Date Unaudited Financial Results For The Quarter Ended 30Th June, 2026 As Per Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
Attachments (1)
📄pdf
Download →
4fafb3e5-92e1-4118-9a48-7dbb9d6b9ec3.pdf
View document text
Established in 1901 CIN L33119UR1981PLC006092
DESH RAKSHAK AUSHDHALAYA LIMITED
BHAGWANT KUTI KANKHAL-249408, HARIDWAR (UTTARAKHAND) INDIA
Manufacturers of Ayurvedic and Herbal Product
Phone: (01334) 243833, 245877, 242333 Tele Fax: (01334) 245866
E-mail: dral95@yahoo.com, dral96@yahoo.in website: www.deshrakshak.in
To, Date: 13.08.2026
Corporate Compliance Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai- 400001
BSE Scrip Code: 531521
Sub- Submission of Quarterly and Year to date Unaudited Financial Results for the quarter
ended 30th June, 2026 as per Regulation 33 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements), Regulations, 2015.
Respected Sir/Mam,
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 mentioned in the captioned subject, the company Desh
Rakshak Aushdhalaya Limited (“the Company”) (CIN: L33119UR1981PLC006092) are
enclosing herewith Financial Results for the quarter and year to date ended 30th June, 2026 which
already approved by the Board of Directors of the Company at the Meeting held on Thursday,
August 13, 2026, Limited Review Report on the Financial Results for the quarter and year to date
ended June 30, 2026 and Declaration on unmodified opinion in respect of the Limited Review
Report.
You are requested to take on the record and do the needful.
Thanking You,
Yours Faithfully
For Desh RakshakAushdhalaya Limited
Tosh Kumar Jain
(Managing Director)
DIN: 01540363
Date: 13.08.2026
Place: Haridwar
J"'"
ANIL & Co. 10, Guru Mandai Ashram
CHARTEREDACCOUNTANTS Devpura,HARIDWAR-249401
Phone: 9837072210
IndependentAuditor's Limited Review Report on Standalone Unaudited Quarterly/Half
YearlyNearto dateFinancialResultsof the DeshRakshakAushdhalayaLimited pursuant
to the Regulation33of the Securities and ExchangeBoard of India (Listing Obligations
andDisclosureRequirements)Regulations.2015(asamended).
Reviewreportto
TheBoardof Directors,
DeshRakshakAushdhalayaLimited
BhagwantKuti Kankhal,Haridwar,Uttarakhand-249408India
We have reviewed the accompanying statement of Unauditedfinancial results
("theStatement")of DeshRakshakAushdhalayaLimitedfor theQuarterandthreeMonths
endedJune 30,2026,being submitted by the company pursuant to the requirementsof
Regulation33of the Securitiesand ExchangeBoardof India("SEBI") (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (as amended) including relevant
circulars issued bythe SEBIfrom time to time.This statementis the responsibility of the
Company's Management and has been approved by the Board of Directors. Our
responsibilityisto issueareportonthesefinancial statementsbasedonour review.
We conducted our review of the Statement in accordance with the Standard on
ReviewEngagements (SRE) 2410 "Review of Interim Financial Information Performed
by the Independent Auditor of the Entity", issued by the lnstitute of Chartered
Accountantsof India.Thisstandardrequiresthatweplanandperformthe reviewto obtain
moderate assurance as to whether the financial statements are free of material
misstatement. A review is limited primarily to inquiries of company personnel and
analyticalproceduresappliedto financial dataand thus provides less assurance than
an audit. Wehavenot performedanaudit andaccordingly, we do not expressanaudit
opiniolJ:
Basedon our reviewconducted asabove,nothing hascometo our attention that causes
usto believethat the accompanyingstatementof Unauditedfinancial results preparedin
accordance with applicable accounting standards and other recognized accounting
practicesandpolicies hasnotdisclosedthe information requiredto bedisclosed interms
of Regulation33of the Securities and ExchangeBoardof India(Listing Obligations and
DisclosureRequirements)Regulations,2015,asamended,including the mannerin which
it isto bedisclosed,orthat itcontainsanymaterialmisstatement.
OurconclusionontheStatementis notmodifiedinrespectoftheabovematter.
FOR AND ON BEHALF OF
MIS ANIL JAIN & CO.
CHARTERED ACCOU NTANTS
PLACE: HARIDWAR
DATED: 13.08.2026
Desh Rakshak Aushdhalaya Limited
CIN:L33119UR1981PLC006092
R/o: Bhagwant Kuti Kankhal, Haridwar, Utttarakhand- 249408 India
Email Id: dral96@yahoo.in; Website: www.deshrakshak.in
STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR TO DATE ENDED 30TH JUNE, 2026
(Rupees in Lakhs Except Earning Per Equity Share and Face Value Per Equity Share)
Particulars Quarter Ended (3 Months Ended) Year Ended
30-Jun-2026 31-Mar-2026 30-Jun-2025 31-Mar-2026 31-Mar-2025
(Refer Notes Below) Un Audited Audited UnAudited Audited Audited
I. Revenue from operations 82.83 345.33 129.99 710.44 627.06
II. Other Income 0.00 1.05 0.00 1.05 3.32
III. Total Revenue (I)+(II) 82.83 346.38 129.99 711.49 630.38
IV. Expenses
Cost of Materials consumed 8.22 180.91 50.33 298.33 256.77
Purchase of stock in trade 0.00 0.00 0.00 0.00 0.00
Changes in inventories of raw material, work-in-progress and 0.00 0.00 0.00 0.00 0.00
finished goods-in-trade
Employees benefits expense 22.89 26.81 26.04 103.12 96.62
Finance Cost 5.40 9.61 5.41 28.40 29.81
Depreciation and amortisation expense 10.91 12.80 10.04 43.64 41.60
Other expenses 27.38 75.45 28.58 170.48 149.11
Total Expenses 74.80 305.58 120.40 643.97 573.91
V. Profit/(Loss) before exceptional and extraordinary items and tax 8.03 40.80 9.59 67.52 56.47
(III- IV)
VI. Exceptional items 0.00 0.00 0.00 0.00 0.00
VII. Profit/(Loss) before extraordinary items and tax (V-VI) 8.03 40.80 9.59 67.52 56.47
VIII. Extraordinary items 0.00 0.00 0.00 0.00 0.00
IX. Profit and Losses before taxes ( VII- VIII) 8.03 40.80 9.59 67.52 56.47
X. Tax Expense
(1) Current tax 0.00 11.30 0.00 11.30 8.81
(2) Deferred tax 0.00 0.00 0.00 0.00 0.00
XI. Net Profit/(Loss) for the period from continuing operations (IX- 8.03 29.50 9.59 56.22 47.66
XII. Profit/(Loss) from discontinuing operations 0.00 0.00 0.00 0.00 0.00
XIII. Tax expense of discontinuing operations 0.00 0.00 0.00 0.00 0.00
0.00
XIV. Profit/(Loss) from Discontinuing operations (after tax) (XII-XIII) 0.00 0.00 0.00 0.00
XV. Profit/(Loss) for the period (XI+XIV) 8.03 29.50 9.59 56.22 47.66
XVI. Other Comprehensive Income / (Expense) (OCI)
A. (i) Items that will not be reclassified to Profit or loss 0.00 0.00 0.00 0.00 0.00
(ii) Income tax relating to items that will not be reclassified to 0.00
Profit or Loss 0.00 0.00 0.00 0.00
B. (i) Items that will be reclassified to Profit or loss 0.00 0.00 0.00 0.00 0.00
(ii) Income tax relating to items that will be reclassified to Profit or 0.00
Loss 0.00 0.00 0.00 0.00
0.00
Total Other Comprehensive Income / (Expense) (OCI) (A+ B) 0.00 0.00 0.00 0.00
8.03 56.22
Total Comprehensive Income/ (Expense) for the period (XV+XVI) 29.50 9.59 47.66
XVII. Paid-up equity share capital (Face Value of the share shall be
569.83 569.83 443.83 569.83 443.83
indicated)
Face Value Per Equity Share 10.00 10.00 10.00 10.00 10.00
XVIII. Reserve excluding revaluation reserves as per balance sheet
523.61 475.94
of previous accounting year
XIX. Earning Per Equity Share
(a) Basic 0.14 0.52 0.22 0.99 1.07
(b) Diluted 0.14 0.52 0.22 0.99 1.07
Notes
(1) The above results have been reviewed by the Audit Committee and taken on record by the Board of Directors at their Meeting held on 13th day of August, 2026. .
(2) The above results have been reviewed by the Statutory Auditors of the Company.
(3)Previous quarter/year figures have been restated wherever necessary to make them comparable.
(4) Disclosure of segment wise information as per AS-17 is not applicable, as dealing with Ayurvedic Medicines is the company's only business Segments
(5) In terms of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, there were no investor complaint pending at
the beginning of the quarter or lying unresolved at 30-06-2026.
(6) The members of the Company in the Extra-Ordinary General M
[Showing first 8,000 characters — download PDF for full document]